Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,72 NOK | -1,04% | +7,92% | +17,70% |
Omzet 2023 | - | Omzet 2024 * | 6,3 mln. 571K 534K | Marktkapitalisatie | 229 mln. 20,79 mln. 19,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -87 -7,89 -7,38 | Nettowinst (verlies) 2024 * | - | EV/omzet 2023 * | - |
Nettoliquiditeiten 2023 * | 49,6 mln. 4,5 mln. 4,21 mln. | Nettoliquiditeiten 2024 * | 61,8 mln. 5,61 mln. 5,24 mln. | EV/omzet 2024 * | 26,6 x |
K/w-verhouding 2023 * |
-
| K/w-verhouding 2024 * |
-
| Werknemers | 8 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 53,93% |
Recentste transcriptie over Lytix Biopharma
1 dag | -1,04% | ||
1 week | +7,92% | ||
Lopende maand | -6,23% | ||
1 maand | -6,23% | ||
3 maanden | -23,22% | ||
6 maanden | -10,62% | ||
Lopend jaar | +17,70% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Øystein Rekdal
CEO | Chief Executive Officer | - | 01-01-03 |
Gjest Breistein
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 01-01-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kjetil Hestdal
BRD | Director/Board Member | 64 | 07-06-21 |
Director/Board Member | 66 | 07-06-21 | |
Jayson M. Rieger
BRD | Director/Board Member | 48 | 07-06-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 5,72 | -1,04% | 113 426 |
25-04-24 | 5,78 | +7,04% | 204 090 |
24-04-24 | 5,4 | +0,75% | 14 221 |
23-04-24 | 5,36 | -3,60% | 85 174 |
22-04-24 | 5,56 | +4,91% | 12 663 |
Real Time Oslo Bors, 26 april 2024 om 16:45 uur
Meer koersenChiffre d''affaires - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,70% | 20,75 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |